| 1 |  LLY•US•NYSE·Options $845.77B·$992.72Live·-2.03% | | $845.77B | $992.72Live | -2.03% | 1.1M | |
| 2 |  JNJ•US•NYSE·Options $532.77B·$226.07Live·-1.42% | | $532.77B | $226.07Live | -1.42% | 2.5M | |
| 3 |  ABBV•US•NYSE·Options $356.49B·$208.64Live·-1.10% | | $356.49B | $208.64Live | -1.10% | 14 | |
| 4 |  UnitedHealth Group Incorporated UNH•US•NYSE·Options $345.08B·$389.21Live·+4.67% | | $345.08B | $389.21Live | +4.67% | 2.8M | |
| 5 |  RO•CH•SW $329.48B·$421.83Live·-1.39% | | $329.48B | $421.83Live | -1.39% | 23.3K | |
| 6 |  ROG•CH•SW $329.38B·$411.94·-6.01% | | $329.38B | $411.94 | -6.01% | 1.1M | |
| 7 | RO ROP•CH•SW $322.74B·$412.97Live·-0.78% | | $322.74B | $412.97Live | -0.78% | 641.1K | |
| 8 |  AZN•US•NASDAQ·Options $283.47B·$185.50Live·-1.65% | | $283.47B | $185.50Live | -1.65% | 671.5K | |
| 9 |  NOVN•CH•SW $277.84B·$148.87Live·-1.68% | | $277.84B | $148.87Live | -1.68% | 2.3M | |
| 10 |  MRK•US•NYSE·Options $275.09B·$113.08Live·-2.01% | | $275.09B | $113.08Live | -2.01% | 1.9M | |
| 11 |  NOVO-B•DK•CO $197.47B·$46.67Live·+2.39% | | $197.47B | $46.67Live | +2.39% | 5.6M | |
| 12 | AM AMGN•US•NASDAQ·Options $179.12B·$335.95Live·-0.46% | | $179.12B | $335.95Live | -0.46% | 57 | |
| 13 |  Thermo Fisher Scientific Inc TMO•US•NYSE·Options $172.80B·$460.76Live·-4.30% | | $172.80B | $460.76Live | -4.30% | 888.1K | |
| 14 | IU IUI1•DE•XETRA $158.84B·$421.69·-6.19% | | $158.84B | $421.69 | -6.19% | 927 | |
| 15 | AB ABT•US•NYSE·Options $146.87B·$83.85Live·-4.33% | | $146.87B | $83.85Live | -4.33% | 96 | |
| 16 |  DHR•US•NYSE·Options $121.14B·$167.21Live·-4.80% | | $121.14B | $167.21Live | -4.80% | 1.4M | |
| 17 | TE TEVA•IL $115.88B·$10,550.00·+2.53% | | $115.88B | $10,550.00 | +2.53% | 909.2K | |
| 18 |  CVS•US•NYSE·Options $115.54B·$93.97Live·+6.17% | | $115.54B | $93.97Live | +6.17% | 4.5M | |
| 19 |  Bristol-Myers Squibb Company BMY•US•NYSE·Options $113.68B·$56.86Live·-1.63% | | $113.68B | $56.86Live | -1.63% | 2.9M | |
| 20 |  SAN•FR•PA $103.43B·$86.28Live·-1.90% | | $103.43B | $86.28Live | -1.90% | 2.5M | |
| 21 |  EL•FR•PA $92.58B·$195.11Live·-5.49% | | $92.58B | $195.11Live | -5.49% | 795.6K | |
| 22 |  CHUGAI PHARMACEUTICAL CO.,LTD. 4519•JP $88.85B·$50.73·-3.54% | | $88.85B | $50.73 | -3.54% | 3.0M | |
| 23 |  ELV•US•NYSE·Options $82.10B·$381.75·+1.88% | | $82.10B | $381.75 | +1.88% | 1.9M | |
| 24 |  BSX•US•NYSE·Options $80.16B·$53.37·-4.70% | | $80.16B | $53.37 | -4.70% | 21.6M | |
| 25 |  CI•US•NYSE·Options $76.20B·$289.07·+2.51% | | $76.20B | $289.07 | +2.51% | 1.3M | |
| 26 | 12 Jiangsu Hengrui Pharma Co Ltd 1276•HK•HK $55.49B·$8.44·+0.92% | | $55.49B | $8.44 | +0.92% | 4.1M | |
| 27 | 77 7741•JP $54.20B·$173.74·-2.14% | | $54.20B | $173.74 | -2.14% | 1.2M | |
| 28 |  UCB•BE•BR $52.41B·$283.79Live·-0.08% | | $52.41B | $283.79Live | -0.08% | 244.0K | |
| 29 |  Takeda Pharmaceutical Company Limited 4502•JP $51.69B·$32.93·-1.47% | | $51.69B | $32.93 | -1.47% | 4.7M | |
| 30 | 60 Jiangsu Hengrui Medicine Co Ltd 600276•CN•SHG $51.55B·$7.87·-0.21% | | $51.55B | $7.87 | -0.21% | 102.3M | |
| 31 |  COR•US•NYSE·Options $50.80B·$259.70·+2.75% | | $50.80B | $259.70 | +2.75% | 2.7M | |
| 32 | GA GALD•CH•SW $49.38B·$211.11·-3.86% | | $49.38B | $211.11 | -3.86% | 363.5K | |
| 33 | 68 688235•CN•SHG $49.27B·$38.53·+6.17% | | $49.27B | $38.53 | +6.17% | 6.2M | |
| 34 |  603259•CN•SHG $46.96B·$15.99·-0.26% | | $46.96B | $15.99 | -0.26% | 53.9M | |
| 35 | EW Edwards Lifesciences Corporation EWL•DE•XETRA $46.69B·$76.61·-7.55% | | $46.69B | $76.61 | -7.55% | 5 | |
| 36 |  Sun Pharmaceutical Industries Limited SUNPHARMA•IN•NSE $46.58B·$19.82·+1.22% | | $46.58B | $19.82 | +1.22% | 2.6M | |
| 37 |  207940•KR•KO $46.33B·$681.77·+0.00% | | $46.33B | $681.77 | +0.00% | 71.6K | |
| 38 | EW Edwards Lifesciences Corp EW•US•NYSE·Options $46.04B·$77.17·-7.25% | | $46.04B | $77.17 | -7.25% | 5.3M | |
| 39 | SH SHL•DE•XETRA $44.28B·$39.48·-5.73% | | $44.28B | $39.48 | -5.73% | 971.1K | |
| 40 |  CSL•AU•AU $43.67B·$72.88·-19.13% | | $43.67B | $72.88 | -19.13% | 4.9M | |
| 41 |  LONN•CH•SW $43.33B·$618.87·-2.39% | | $43.33B | $618.87 | -2.39% | 138.3K | |
| 42 | CA CAH•US•NYSE·Options $43.01B·$182.50·-4.69% | | $43.01B | $182.50 | -4.69% | 2.0M | |
| 43 |  BAYN•DE•XETRA $42.73B·$43.61·-3.71% | | $42.73B | $43.61 | -3.71% | 1.8M | |
| 44 |  Becton Dickinson and Company BDX•US•NYSE·Options $41.17B·$143.15·-1.11% | | $41.17B | $143.15 | -1.11% | 3.4M | |
| 45 |  Alnylam Pharmaceuticals Inc ALNY•US•NASDAQ·Options $39.51B·$284.84·-5.99% | | $39.51B | $284.84 | -5.99% | 1.2M | |
| 46 | SD SDZ•CH•SW $37.17B·$85.80·-0.60% | | $37.17B | $85.80 | -0.60% | 612.9K | |
| 47 |  DAIICHI SANKYO COMPANY,LIMITED 4568•JP $35.94B·$16.90·+1.24% | | $35.94B | $16.90 | +1.24% | 11.5M | |
| 48 | MD Medline Inc. Class A Common Stock MDLN•US•NASDAQ·Options $34.63B·$39.25·-6.57% | | $34.63B | $39.25 | -6.57% | 7.4M | |
| 49 |  6160•HK•HK $32.50B·$24.34·+4.67% | | $32.50B | $24.34 | +4.67% | 4.0M | |
| 50 |  A•US•NYSE·Options $31.63B·$111.46·-5.29% | | $31.63B | $111.46 | -5.29% | 2.2M | |